The Anti-inflammatory Drug BAY 11-7082 Suppresses the MyD88-dependent Signalling Network by Targeting the Ubiquitin System

Overview

Journal Biochem J

Specialty Biochemistry

Date 2013 Feb 28

PMID 23441730

Citations 100

Authors

Sam Strickson

David G Campbell

Christoph H Emmerich

Axel Knebel

Lorna Plater

Maria Stella Ritorto

Natalia Shpiro

Philip Cohen

Affiliations

Soon will be listed here.

Abstract

The compound BAY 11-7082 inhibits IκBα [inhibitor of NF-κB (nuclear factor κB)α] phosphorylation in cells and has been used to implicate the canonical IKKs (IκB kinases) and NF-κB in >350 publications. In the present study we report that BAY 11-7082 does not inhibit the IKKs, but suppresses their activation in LPS (lipopolysaccharide)-stimulated RAW macrophages and IL (interleukin)-1-stimulated IL-1R (IL-1 receptor) HEK (human embryonic kidney)-293 cells. BAY 11-7082 exerts these effects by inactivating the E2-conjugating enzymes Ubc (ubiquitin conjugating) 13 and UbcH7 and the E3 ligase LUBAC (linear ubiquitin assembly complex), thereby preventing the formation of Lys63-linked and linear polyubiquitin chains. BAY 11-7082 prevents ubiquitin conjugation to Ubc13 and UbcH7 by forming a covalent adduct with their reactive cysteine residues via Michael addition at the C3 atom of BAY 11-7082, followed by the release of 4-methylbenzene-sulfinic acid. BAY 11-7082 stimulated Lys48-linked polyubiquitin chain formation in cells and protected HIF1α (hypoxia-inducible factor 1α) from proteasomal degradation, suggesting that it inhibits the proteasome. The results of the present study indicate that the anti-inflammatory effects of BAY 11-7082, its ability to induce B-cell lymphoma and leukaemic T-cell death and to prevent the recruitment of proteins to sites of DNA damage are exerted via inhibition of components of the ubiquitin system and not by inhibiting NF-κB.

Citing Articles

The alternative polyadenylation regulator CFIm25 promotes macrophage differentiation and activates the NF-κB pathway.

Mukherjee S, Barua A, Wang L, Tian B, Moore C Cell Commun Signal. 2025; 23(1):115.

PMID: 40022203 PMC: 11871739. DOI: 10.1186/s12964-025-02114-1.

Tumor vascular endothelial cells promote immune escape by upregulating PD-L1 expression via crosstalk between NF-κB and STAT3 signaling pathways in nasopharyngeal carcinoma.

Wang Y, Chen Y, Liu Y, Zhao J, Wang G, Chen H Cell Death Dis. 2025; 16(1):129.

PMID: 40000620 PMC: 11861260. DOI: 10.1038/s41419-025-07444-z.

Small molecule targeted protein degradation the UPS: venturing beyond E3 substrate receptors.

Guo R, Yang F, Cherney E RSC Med Chem. 2025; .

PMID: 39949641 PMC: 11815867. DOI: 10.1039/d4md00718b.

Alda‑1 restores ALDH2‑mediated alcohol metabolism to inhibit the NF‑κB/VEGFC axis in head and neck cancer.

Lin Y, Lee Y, Liao J, Yu P, Chou C, Yang Y Int J Mol Med. 2025; 55(4).

PMID: 39886980 PMC: 11819766. DOI: 10.3892/ijmm.2025.5496.

Inflammatory disease progression shapes nanoparticle biomolecular corona-mediated immune activation profiles.

Shaw J, Caprio N, Truong N, Weldemariam M, Tran A, Pilli N Nat Commun. 2025; 16(1):924.

PMID: 39843415 PMC: 11754911. DOI: 10.1038/s41467-025-56210-4.

References

Waterfield M, Jin W, Reiley W, Zhang M, Sun S . IkappaB kinase is an essential component of the Tpl2 signaling pathway. Mol Cell Biol. 2004; 24(13):6040-8. PMC: 480897. DOI: 10.1128/MCB.24.13.6040-6048.2004. View

Pauls E, Shpiro N, Peggie M, Young E, Sorcek R, Tan L . Essential role for IKKβ in production of type 1 interferons by plasmacytoid dendritic cells. J Biol Chem. 2012; 287(23):19216-28. PMC: 3365954. DOI: 10.1074/jbc.M112.345405. View

Soucy T, Smith P, Milhollen M, Berger A, Gavin J, Adhikari S . An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer. Nature. 2009; 458(7239):732-6. DOI: 10.1038/nature07884. View

Ngo V, Young R, Schmitz R, Jhavar S, Xiao W, Lim K . Oncogenically active MYD88 mutations in human lymphoma. Nature. 2010; 470(7332):115-9. PMC: 5024568. DOI: 10.1038/nature09671. View

Martin M, Wesche H . Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family. Biochim Biophys Acta. 2002; 1592(3):265-80. DOI: 10.1016/s0167-4889(02)00320-8. View

Scaife C, Kuang J, Wills J, Trowbridge D, Gray P, Manning B . Nuclear factor kappaB inhibitors induce adhesion-dependent colon cancer apoptosis: implications for metastasis. Cancer Res. 2002; 62(23):6870-8. View

Clark K, Peggie M, Plater L, Sorcek R, Young E, Madwed J . Novel cross-talk within the IKK family controls innate immunity. Biochem J. 2010; 434(1):93-104. DOI: 10.1042/BJ20101701. View

Deng L, Wang C, Spencer E, Yang L, Braun A, You J . Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell. 2000; 103(2):351-61. DOI: 10.1016/s0092-8674(00)00126-4. View

Shim J, Xiao C, Paschal A, Bailey S, Rao P, Hayden M . TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev. 2005; 19(22):2668-81. PMC: 1283960. DOI: 10.1101/gad.1360605. View

10.

Kanayama A, Seth R, Sun L, Ea C, Hong M, Shaito A . TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains. Mol Cell. 2004; 15(4):535-48. DOI: 10.1016/j.molcel.2004.08.008. View

11.

Mori N, Fujii M, Ikeda S, Yamada Y, Tomonaga M, Ballard D . Constitutive activation of NF-kappaB in primary adult T-cell leukemia cells. Blood. 1999; 93(7):2360-8. View

12.

Sato S, Sanjo H, Takeda K, Ninomiya-Tsuji J, Yamamoto M, Kawai T . Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat Immunol. 2005; 6(11):1087-95. DOI: 10.1038/ni1255. View

13.

Wu C, Conze D, Li T, Srinivasula S, Ashwell J . Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected]. Nat Cell Biol. 2006; 8(4):398-406. DOI: 10.1038/ncb1384. View

14.

Nanda S, Venigalla R, Ordureau A, Patterson-Kane J, Powell D, Toth R . Polyubiquitin binding to ABIN1 is required to prevent autoimmunity. J Exp Med. 2011; 208(6):1215-28. PMC: 3173241. DOI: 10.1084/jem.20102177. View

15.

Wenzel D, Lissounov A, Brzovic P, Klevit R . UBCH7 reactivity profile reveals parkin and HHARI to be RING/HECT hybrids. Nature. 2011; 474(7349):105-8. PMC: 3444301. DOI: 10.1038/nature09966. View

16.

Pulvino M, Liang Y, Oleksyn D, DeRan M, Van Pelt E, Shapiro J . Inhibition of proliferation and survival of diffuse large B-cell lymphoma cells by a small-molecule inhibitor of the ubiquitin-conjugating enzyme Ubc13-Uev1A. Blood. 2012; 120(8):1668-77. PMC: 3429308. DOI: 10.1182/blood-2012-02-406074. View

17.

Windheim M, Peggie M, Cohen P . Two different classes of E2 ubiquitin-conjugating enzymes are required for the mono-ubiquitination of proteins and elongation by polyubiquitin chains with a specific topology. Biochem J. 2007; 409(3):723-9. DOI: 10.1042/BJ20071338. View

18.

Xia Z, Sun L, Chen X, Pineda G, Jiang X, Adhikari A . Direct activation of protein kinases by unanchored polyubiquitin chains. Nature. 2009; 461(7260):114-9. PMC: 2747300. DOI: 10.1038/nature08247. View

19.

Kensche T, Tokunaga F, Ikeda F, Goto E, Iwai K, Dikic I . Analysis of nuclear factor-κB (NF-κB) essential modulator (NEMO) binding to linear and lysine-linked ubiquitin chains and its role in the activation of NF-κB. J Biol Chem. 2012; 287(28):23626-34. PMC: 3390637. DOI: 10.1074/jbc.M112.347195. View

20.

Ea C, Deng L, Xia Z, Pineda G, Chen Z . Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol Cell. 2006; 22(2):245-57. DOI: 10.1016/j.molcel.2006.03.026. View